BioPharma Credit PLC
BPCP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £4 | £6 | £37 | £135 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £54 | £32 | £37 | £20 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £59 | £37 | £74 | £155 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £1,099 | £1,162 | £1,157 | £1,201 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £1,099 | £1,162 | £1,157 | £1,201 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,158 | £1,200 | £1,232 | £1,357 |
| Liabilities | – | – | – | – |
| Payables | £0 | £1 | £0 | £0 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £0 | -£14 | £0 | -£12 |
| Total Curr. Liab. | £7 | £18 | £3 | £16 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £7 | £18 | £4 | £16 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £14 | £14 | £14 | £14 |
| Retained Earnings | £529 | £561 | £607 | £720 |
| AOCI | £0 | £0 | £0 | £0 |
| Other Equity | £0 | £0 | £0 | £0 |
| Total Equity | £1,150 | £1,182 | £1,228 | £1,341 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1,158 | £1,200 | £1,232 | £1,357 |
| Net Debt | -£4 | -£6 | -£37 | -£135 |